Filed by Bristol-Myers Squibb Company
Pursuant to Rule 425 of the Securities Act of 1933
and deemed filed pursuant to Rule 14a-12
of the Securities Exchange Act of 1934
Form S-4 File No.: 333-229464
Subject Company: Celgene Corporation
SEC File No.: 001-34912
Explanatory Note: The following slides were used by Bristol-Myers Squibb Company at an investor presentation on February 20, 2019.
![](https://capedge.com/proxy/425/0001140361-19-003506/s002621x19_image01.jpg)
![](https://capedge.com/proxy/425/0001140361-19-003506/s002621x19_image02.jpg)
![](https://capedge.com/proxy/425/0001140361-19-003506/s002621x19_image03.jpg)
![](https://capedge.com/proxy/425/0001140361-19-003506/s002621x19_image04.jpg)
![](https://capedge.com/proxy/425/0001140361-19-003506/s002621x19_image05.jpg)
![](https://capedge.com/proxy/425/0001140361-19-003506/s002621x19_image06.jpg)
![](https://capedge.com/proxy/425/0001140361-19-003506/s002621x19_image07.jpg)
![](https://capedge.com/proxy/425/0001140361-19-003506/s002621x19_image08.jpg)
![](https://capedge.com/proxy/425/0001140361-19-003506/s002621x19_image09.jpg)
![](https://capedge.com/proxy/425/0001140361-19-003506/s002621x19_image10.jpg)
![](https://capedge.com/proxy/425/0001140361-19-003506/s002621x19_image11.jpg)
![](https://capedge.com/proxy/425/0001140361-19-003506/s002621x19_image12.jpg)
![](https://capedge.com/proxy/425/0001140361-19-003506/s002621x19_image13.jpg)
![](https://capedge.com/proxy/425/0001140361-19-003506/s002621x19_image14.jpg)
![](https://capedge.com/proxy/425/0001140361-19-003506/s002621x19_image15.jpg)
![](https://capedge.com/proxy/425/0001140361-19-003506/s002621x19_image16.jpg)
![](https://capedge.com/proxy/425/0001140361-19-003506/s002621x19_image17.jpg)
![](https://capedge.com/proxy/425/0001140361-19-003506/s002621x19_image18.jpg)
![](https://capedge.com/proxy/425/0001140361-19-003506/s002621x19_image19.jpg)
![](https://capedge.com/proxy/425/0001140361-19-003506/s002621x19_image20.jpg)
![](https://capedge.com/proxy/425/0001140361-19-003506/s002621x19_image21.jpg)
![](https://capedge.com/proxy/425/0001140361-19-003506/s002621x19_image22.jpg)
![](https://capedge.com/proxy/425/0001140361-19-003506/s002621x19_image23.jpg)
![](https://capedge.com/proxy/425/0001140361-19-003506/s002621x19_image24.jpg)
![](https://capedge.com/proxy/425/0001140361-19-003506/s002621x19_image25.jpg)
![](https://capedge.com/proxy/425/0001140361-19-003506/s002621x19_image26.jpg)
![](https://capedge.com/proxy/425/0001140361-19-003506/s002621x19_image27.jpg)
![](https://capedge.com/proxy/425/0001140361-19-003506/s002621x19_image28.jpg)
![](https://capedge.com/proxy/425/0001140361-19-003506/s002621x19_image29.jpg)
![](https://capedge.com/proxy/425/0001140361-19-003506/s002621x19_image30.jpg)
![](https://capedge.com/proxy/425/0001140361-19-003506/s002621x19_image31.jpg)
![](https://capedge.com/proxy/425/0001140361-19-003506/s002621x19_image32.jpg)
![](https://capedge.com/proxy/425/0001140361-19-003506/s002621x19_image33.jpg)
![](https://capedge.com/proxy/425/0001140361-19-003506/s002621x19_image34.jpg)
![](https://capedge.com/proxy/425/0001140361-19-003506/s002621x19_image35.jpg)
![](https://capedge.com/proxy/425/0001140361-19-003506/s002621x19_image36.jpg)
![](https://capedge.com/proxy/425/0001140361-19-003506/s002621x19_image37.jpg)